NEW YORK, Oct. 10, 2024 /PRNewswire/ — AEYE Health, the leader in AI diagnostic screening, will showcase the only FDA-cleared portable AI solution for autonomous diabetic retinopathy screening that does not require physician interpretation at key industry events. This groundbreaking technology enables on-the-spot and highly accurate retinal screenings at any point of care – either in clinics or at home, improving accessibility and early detection. AEYE-DS with a portable camera will be present at several major conferences:

Read more here.